It’s interesting. The regulation ostensibly protects vulnerable classes from exploitation and lets them use reimbursement structures to defray cost. At the same time it causes costs to go up and allows people to buy their way across the moat.

I wonder if regulation that stipulated that a change of ownership of some percentage would require recertification of the entity would stem this a bit. Or restrictions on buying HIPAA covered businesses with patient data. Might pose a problem to folks in the business today, but could slow down the massive acquire-and-merge train in these industries.